Debra Miller is the founder and CEO of CureDuchenne, and in this video she discusses some of the current clinical research in Duchenne muscular dystrophy (DMD) and the hope of a possible cure.
Debra founded CureDuchenne in 2003 with her husband after their only son was diagnosed with Duchenne. The funds CureDuchenne raise support research programs aimed at treating and curing the disease.
CureDuchenne has leveraged more than $1.3 billion in follow-on investment from venture capital, biotech, and pharmaceutical companies to fund Duchenne research. To date, 10 CureDuchenne research projects have advanced into human clinical trials, including one that resulted in the first FDA approved drug for Duchenne.